What are Ozempic, Wegovy, Mounjaro and Zepbound approved to treat
31 In September 2025, the FDA issued over 50 warning letters to facilities using salt forms
Topics of discussion will include: Monitoring, assessing, and ensuring adequate pharmacovigilance across GLP-1 drugs and manufacturing Flagging and remedying serious adverse effects associated with GLP-1s before facing suit Anticipating and preparing for MDLs and class actions Preempting issues caused by GLP-1 usage Afternoon Networking Break Phyllis Hurwitz MarcusVice President, National Advertising DivisionBBB National Programs Maria RisingInfluencerTirzepatide Tales & The Rising Project Claire DaviesShareholderPolsinelli From television to TikTok, from busses to subways, from podcasts to newspapers, it is impossible to escape GLP-1 advertisements in 2026
How to protect your muscle mass
Peptides for Women : While the dose is the same, women may be more sensitive to the side effects of certain peptides, such as the water retention associated with higher doses of GH-releasing peptides
